Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Edward A. Stadtmauer

1-50 of 245 results

View this query on the Wikidata Query Service
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

scientific article published in June 2005
Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America

scientific article
Lenalidomide after stem-cell transplantation for multiple myeloma

scientific article
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.

scientific article published on 14 June 2013
Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma

scientific article
A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma

scientific article
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse

scientific article (publication date: July 2001)
Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells

scientific article published on August 2013
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

scientific article
Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma

scientific article
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.

scientific article
Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma

scientific article
Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial

scientific article
Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial

scientific article published on 09 August 2007
Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer

scientific article published on 16 October 2005
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

scientific article published on September 8, 2010
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence

scientific article
Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group

scientific article
Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline

scientific article
Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients

scientific article published on April 2001
Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial

scientific article published on September 29, 2011
Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma

scientific article
Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine

scientific article
Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study

scientific article published on 18 August 2008
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America

scientific article published on 01 May 1997
Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease

scientific article published on July 12, 2012
A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation

scientific article published on 3 November 2005
Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens

scientific article published on 26 June 2009
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100).

scientific article published on 25 June 2009
Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation

scientific article published on 22 May 2003
Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial

scientific article
Treatment of PTLD with rituximab or chemotherapy

scientific article published in March 2006
Post-transplant lymphoproliferative disorder: a review

scientific article
Carfilzomib, pomalidomide, and dexamethasone for relapsed or refractory myeloma.

scientific article
Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma.

scientific article
Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin).

scientific article
Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials

scientific article published on 09 November 2006
Lenalidomide in combination with dexamethasone at first relapse in comparison with its use as later salvage therapy in relapsed or refractory multiple myeloma.

scientific article published on 19 March 2009
Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials networ

scientific article published on February 12, 2011
Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study

scientific article
Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the

scientific article published on March 11, 2013
A phase 1 study of lucatumumab, a fully human anti‐CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma

scientific article published on August 4, 2012
Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★

scientific article published on January 10, 2011
Bortezomib is active in patients with untreated or relapsed Waldenstrom's macroglobulinemia: a phase II study of the National Cancer Institute of Canada Clinical Trials Group

scientific article
Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma

scientific article
Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial

scientific article published on 01 September 2001
A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia.

scientific article published on 20 October 2009
The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function

scientific article
Rapid immune recovery and graft-versus-host disease-like engraftment syndrome following adoptive transfer of Costimulated autologous T cells.

scientific article
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia

scientific article

Paulina is supported by:

About Paulina

Help